instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychomotor hyperactivity'. | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | FINGOLIMOD | DrugsGivenReaction | CC BY | 34777236 | 20,118,694 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | FINGOLIMOD | DrugsGivenReaction | CC BY | 34777236 | 20,118,694 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | FINGOLIMOD, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34777236 | 20,210,520 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumefactive multiple sclerosis'. | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | FINGOLIMOD | DrugsGivenReaction | CC BY | 34777236 | 20,118,694 | 2021 |
What was the administration route of drug 'FINGOLIMOD'? | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | Oral | DrugAdministrationRoute | CC BY | 34777236 | 20,118,694 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34777236 | 20,210,520 | 2021 |
What was the outcome of reaction 'Disease recurrence'? | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | Recovering | ReactionOutcome | CC BY | 34777236 | 20,210,520 | 2021 |
What was the outcome of reaction 'Neuropsychiatric symptoms'? | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | Recovering | ReactionOutcome | CC BY | 34777236 | 20,203,347 | 2021 |
What was the outcome of reaction 'Treatment failure'? | Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid advers... | Not recovered | ReactionOutcome | CC BY | 34777236 | 20,210,520 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholestasis'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,169,004 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,169,004 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyslipidaemia'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,169,004 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis fulminant'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,169,004 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperlipidaemia'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,187,051 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multi-organ disorder'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,169,004 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudohyponatraemia'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,168,438 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Xanthoma'. | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34777814 | 20,169,004 | 2021 |
What was the outcome of reaction 'Cholestasis'? | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | Recovering | ReactionOutcome | CC BY | 34777814 | 20,169,004 | 2021 |
What was the outcome of reaction 'Hepatitis fulminant'? | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | Recovering | ReactionOutcome | CC BY | 34777814 | 20,169,004 | 2021 |
What was the outcome of reaction 'Hyperlipidaemia'? | Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report.
Cutaneous xanthomas are the result of dermal deposition of lipid, mostly caused by disorders of lipid metabolism. Less commonly, they occur in the setting of cholestatic liver disease, lea... | Recovered | ReactionOutcome | CC BY | 34777814 | 20,187,051 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old... | AMPHOTERICIN B | DrugsGivenReaction | CC BY | 34777880 | 20,111,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old... | AMPHOTERICIN B | DrugsGivenReaction | CC BY | 34777880 | 20,111,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old... | AMPHOTERICIN B | DrugsGivenReaction | CC BY | 34777880 | 20,111,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old... | AMPHOTERICIN B | DrugsGivenReaction | CC BY | 34777880 | 20,953,815 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old... | Fatal | ReactionOutcome | CC BY | 34777880 | 20,111,075 | 2021 |
What was the outcome of reaction 'Therapy non-responder'? | Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old... | Fatal | ReactionOutcome | CC BY | 34777880 | 20,953,815 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam.
Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are com... | ACETAMINOPHEN\CODEINE PHOSPHATE, CLONIDINE, LEVETIRACETAM, SERTRALINE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34777889 | 20,583,084 | 2021 |
What was the dosage of drug 'CLONIDINE'? | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam.
Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are com... | 75 MICROGRAM, TID | DrugDosageText | CC BY | 34777889 | 20,583,084 | 2021 |
What was the dosage of drug 'TRAZODONE HYDROCHLORIDE'? | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam.
Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are com... | 50 MG, QD | DrugDosageText | CC BY | 34777889 | 20,583,084 | 2021 |
What was the outcome of reaction 'Anxiety'? | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam.
Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are com... | Recovered | ReactionOutcome | CC BY | 34777889 | 20,583,084 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukoencephalopathy'. | CSA-Induced PRES after Heart Transplantation-Report of Two Cases and Review.
Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe P... | CORTISONE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34777943 | 20,157,322 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Posterior reversible encephalopathy syndrome'. | CSA-Induced PRES after Heart Transplantation-Report of Two Cases and Review.
Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe P... | CORTISONE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34777943 | 20,157,322 | 2021-01 |
What was the dosage of drug 'CYCLOSPORINE'? | CSA-Induced PRES after Heart Transplantation-Report of Two Cases and Review.
Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe P... | TARGET LEVEL 200 NG/ML, TWICE DAILY | DrugDosageText | CC BY-NC-ND | 34777943 | 20,157,322 | 2021-01 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | CSA-Induced PRES after Heart Transplantation-Report of Two Cases and Review.
Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe P... | MMF, 2 X 1000MG DAILY | DrugDosageText | CC BY-NC-ND | 34777943 | 20,157,322 | 2021-01 |
What was the outcome of reaction 'Leukoencephalopathy'? | CSA-Induced PRES after Heart Transplantation-Report of Two Cases and Review.
Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe P... | Recovering | ReactionOutcome | CC BY-NC-ND | 34777943 | 20,157,322 | 2021-01 |
What was the outcome of reaction 'Posterior reversible encephalopathy syndrome'? | CSA-Induced PRES after Heart Transplantation-Report of Two Cases and Review.
Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe P... | Recovering | ReactionOutcome | CC BY-NC-ND | 34777943 | 20,157,322 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asphyxia'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,162,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,502,532 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,502,466 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperplasia adrenal'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,162,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung disorder'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,162,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,527,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal aspiration'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,502,532 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal pneumonia'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,502,532 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,527,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,488,726 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'SARS-CoV-2 test positive'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,162,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tissue infiltration'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,162,023 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral infection'. | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | AMOXICILLIN\CLAVULANATE POTASSIUM, AZITHROMYCIN ANHYDROUS, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC-ND | 34777995 | 20,490,542 | 2021 |
What is the weight of the patient? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | 4.24 kg. | Weight | CC BY-NC-ND | 34777995 | 20,502,532 | 2021 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Other | DrugAdministrationRoute | CC BY-NC-ND | 34777995 | 20,490,542 | 2021 |
What was the dosage of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | UNK, UNKNOWN | DrugDosageText | CC BY-NC-ND | 34777995 | 20,488,726 | 2021 |
What was the dosage of drug 'AZITHROMYCIN'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | UNK, UNKNOWN | DrugDosageText | CC BY-NC-ND | 34777995 | 20,488,726 | 2021 |
What was the dosage of drug 'LOPINAVIR\RITONAVIR'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | UNK, UNKNOWN | DrugDosageText | CC BY-NC-ND | 34777995 | 20,488,726 | 2021 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,490,124 | 2021 |
What was the outcome of reaction 'Asphyxia'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,162,023 | 2021 |
What was the outcome of reaction 'COVID-19'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,502,532 | 2021 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,502,466 | 2021 |
What was the outcome of reaction 'Neonatal asphyxia'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,490,542 | 2021 |
What was the outcome of reaction 'Pneumonia aspiration'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,490,542 | 2021 |
What was the outcome of reaction 'Pneumonia viral'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,490,124 | 2021 |
What was the outcome of reaction 'Treatment failure'? | Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs.
In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19 in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to acute respiratory distress syndrome. A stillborn child was removed... | Fatal | ReactionOutcome | CC BY-NC-ND | 34777995 | 20,527,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colorectal cancer metastatic'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conjunctivitis'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis acneiform'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry skin'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypomagnesaemia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nail disorder'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Onycholysis'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palmar-plantar erythrodysaesthesia syndrome'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paronychia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyogenic granuloma'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin fissures'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB | DrugsGivenReaction | CC BY | 34778029 | 20,129,182 | 2021 |
What was the outcome of reaction 'Death'? | Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens i... | Fatal | ReactionOutcome | CC BY | 34778029 | 20,129,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
For most patients suffering from recurrent and/or metastatic head and neck... | CARBOPLATIN, CETUXIMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 34778031 | 20,102,104 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
For most patients suffering from recurrent and/or metastatic head and neck... | AUC2/WEEK, CYCLIC | DrugDosageText | CC BY | 34778031 | 20,102,104 | 2021 |
What was the dosage of drug 'CETUXIMAB'? | Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
For most patients suffering from recurrent and/or metastatic head and neck... | 400 MG/M2 THEN 250 MG/M2/WEEK, CYCLIC | DrugDosageText | CC BY | 34778031 | 20,102,104 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
For most patients suffering from recurrent and/or metastatic head and neck... | 80 MG/M2/WEEK, CYCLIC | DrugDosageText | CC BY | 34778031 | 20,102,104 | 2021 |
What was the outcome of reaction 'Infection'? | Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
For most patients suffering from recurrent and/or metastatic head and neck... | Fatal | ReactionOutcome | CC BY | 34778031 | 20,102,104 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma.
Recently, combination regimens based on programmed cell death-1 (PD-1) blockade have become increasingly common in clinical practice for the treatment of cancer. Such combinations si... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34778042 | 20,215,909 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study.
Initial studies that described the novel coronavirus (COVID-19) reported increased morbidity and mortality in patients with cancer. Of this group, patients with hematologic malignancies (HM) had the highest disease severity and dea... | HYDROXYUREA | DrugsGivenReaction | CC BY | 34778057 | 20,165,030 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study.
Initial studies that described the novel coronavirus (COVID-19) reported increased morbidity and mortality in patients with cancer. Of this group, patients with hematologic malignancies (HM) had the highest disease severity and dea... | HYDROXYUREA | DrugsGivenReaction | CC BY | 34778057 | 20,165,030 | 2021 |
What was the outcome of reaction 'COVID-19'? | COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study.
Initial studies that described the novel coronavirus (COVID-19) reported increased morbidity and mortality in patients with cancer. Of this group, patients with hematologic malignancies (HM) had the highest disease severity and dea... | Fatal | ReactionOutcome | CC BY | 34778057 | 20,165,030 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature.
Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome, and the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated myeloid-related proteinemia inflammatory (PAMI) sy... | CANAKINUMAB, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34778321 | 20,486,510 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature.
Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome, and the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated myeloid-related proteinemia inflammatory (PAMI) sy... | CANAKINUMAB, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34778321 | 20,486,510 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.